RE:RE:NEW NR RE YEAR END DISCLOSURESGV, I was under the impression that with the Hepalink deal that RVX would have enough funds to complete the BETonMACE trial. Of course that goes back a long way and things change.
I'm not too worried. Don will find the funds and also insure that the credit line will be renewed. I really don't believe that NGN, Eastern and/or Hepalink want to disrupt BoM because it is completely to their advantage to keep this moving.
I certainly hope there are no malicious players in this game but when things start to move greed takes over. That is why I like the fact that there are at least 3 big players involved. Then add to that the next regional deal (which Don seemed very confident about)!
It would certainly help if Don makes a definitive statement on these issues but he has 15 years of success under his belt (not that I condone his flippant remarks and attitudes).
I do not expect anything from the AGM.
In the early days I veiwed RVX as a very simple rvx-208 company. But over the years IMHO Don, with the Hepalink deal among all of the previous financings I staretd to realize this organization is far more complex scientifically and from a business strategy point of view.
As I have realized and stated in past posts both Zenith and Resverlogix are really scientific platforms and potential production companies for many indications and the machinery to address needs from other development companies plus the potential for downstream revenue from specific molecules like rvx-208 (apabetalone) and zen3694 in the mCRPC trial.
I'm still pumped.
Cheers
Toinv